Gene · 8880
FUBP1: far upstream element binding protein 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. FUBP1: far upstream element binding protein 1. Genes, record 8880. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/8880
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q96AE4 | Far upstream element-binding protein 1 | 644 | 7 | Ensembl, GeneID, HGNC |
Source UniProt
Patents37
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 45856 | Q96AE4 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 8837 | Q96AE4 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 9056 | Q96AE4 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 15022 | Q96AE4 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 9056 | Q96AE4 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 8837 | Q96AE4 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 15022 | Q96AE4 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 15022 | Q96AE4 | Espacenet |
| JP 2024109657 A | 2024-08-14 | 14861 | Q96AE4 | Espacenet |
| JP 2023522848 A | 2023-06-01 | 26 | Q96AE4 | Espacenet |
1 to 10 of 37
See all 37 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants930
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | FUBP1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 16 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 14 | 2025 |
| P50CA097257 | Brain Tumor SPORE Grant | 13 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 11 | 2025 |
| ZIASC009144 | Mechanisms of transcription factor integration at the c-myc promoter | 11 | 2025 |
| P50CA127001 | SPORE in Brain Cancer | 6 | 2025 |
| P30CA076292 | Moffitt Cancer Center Support Grant | 4 | 2025 |
| ZIABC011011 | The genome-wide function of supercoiling and alternative DNA conformations | 4 | 2025 |
| P01CA013106 | Targeting Transcription and Splicing in Cancer | 3 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 3 | 2025 |
1 to 10 of 930Source NIH's project files
See all 930 nih grantsPapers1,381
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prognostic value of FUBP1 in Colorectal cancer and association with immune microenvironment characteristics. | Cancer Treat Res Commun | 2026 | 42641461 | PubTator, text mining | PubMed |
| FUBL-3/FUBP1 mediates mitochondrial stress-induced chromatin remodeling and longevity. | Sci Adv | 2026 | 42341138 | PubTator, text mining | PubMed |
| The RNA-binding protein RBFOX2 suppresses colorectal cancer proliferation and metastasis by reducing FUBP1 mRNA stability to induce mitochondrial dysfunction and ferroptosis. | Discov Oncol | 2026 | 42223720 | PubTator, text mining | PubMed |
| JARID1B-Mediated H3K4me3 Demethylation Promotes Cisplatin Resistance in Oral Squamous Cell Carcinoma Cells via the miR-495-3p/FUBP1 Axis. | Appl Biochem Biotechnol | 2026 | 42166100 | PubTator, text mining | PubMed |
| Stress granule dynamics orchestrate colitis-to-cancer transition via TOM1-mediated disassembly and driven oncogenesis in response to inflammatory oxidative stress. | Redox Biol | 2026 | 42127552 | PubTator, text mining | PubMed |
| Antiviral activity of novel chemical compound 0411, derived from FUBP1-IN-1 against hepatitis B virus by upregulation of DUSP5. | Biochem Pharmacol | 2026 | 42000079 | PubTator, text mining | PubMed |
| Proteome-based investigation of O-GlcNAcylation in a C. elegans model of ageing and Alzheimer's disease: Functional support for earlier hypothesis-generating findings. | PLoS One | 2026 | 41911326 | PubTator, text mining | PubMed |
| Recent Advances in Targeted Therapies for Adult Gliomas. | Curr Neurol Neurosci Rep | 2026 | 41874881 | PubTator, text mining | PubMed |
| MEG3 in glioma stem cells promotes glioblastoma angiogenesis through FUBP3-mediated VGF expression. | Clin Exp Med | 2026 | 41866561 | PubTator, text mining | PubMed |
| Hybrid tuned deep learning model for breast cancer diagnosis using genetic data. | Sci Rep | 2026 | 41865006 | PubTator, text mining | PubMed |
1 to 10 of 1,381
See all 1,381 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/8880
GET https://conductscience.org/api/genes/v1/8880/patents?page=2